XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.23.1

General (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | Derivative instruments measured at fair value and their classification on the consolidated balance sheets are presented in the following table (in thousands):
| Assets (liabilities) as of March 31, 2023 (unaudited) |  | Liabilities as of December 31, 2022
| Notional Amount |  | Fair Value |  | Notional Amount |  | Fair Value
Foreign exchange forward contract derivatives in cash flow hedging relationships included in accrued expenses and other short-term liabilities | $ | 140,171 |  |  | $ | (10,189) |  |  | $ | 136,426 |  |  | $ | (7,221) |
Foreign exchange forward contract derivatives in cash flow hedging relationships included in long-term other liabilities | $ | 139,165 |  |  | $ | (3,181) |  |  | $ | 107,210 |  |  | $ | (2,060) |
Foreign exchange forward contract derivatives for monetary items included in prepaid expenses and other current assets and accrued expenses and other short-term liabilities | $ | 17,236 |  |  | $ | 18 |  |  | $ | 32,066 |  |  | $ | (226) |
Cash, Cash Equivalents and Investments | The Company considers all investments purchased with original maturities at the date of purchase greater than three months but less than one year to be short-term. Marketable securities are classified as available for sale and are, therefore, recorded at fair value on the consolidated balance sheet, with any unrealized gains and losses reported in accumulated other comprehensive income, which is reflected as a separate component of stockholders’ equity in the Company’s consolidated balance sheets, until realized. The Company uses the specific identification method to compute gains and losses on the investments. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion is included as a component of financial income, net in the consolidated statement of operations. Cash, cash equivalents, marketable securities and deposits consist of the following (in thousands):
| As of March 31, 2023
| (unaudited)
| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value
Cash equivalents |  |  |  |  |  |  |
Money market funds | $ | 162,911 |  |  | $ | — |  |  | $ | — |  |  | $ | 162,911 |
Total | $ | 162,911 |  |  | $ | — |  |  | $ | — |  |  | $ | 162,911 |
Marketable securities |  |  |  |  |  |  |
US Treasury securities | $ | 205,728 |  |  | $ | 118 |  |  | $ | (152) |  |  | $ | 205,694 |
US Agencies securities | 55,976 |  |  | *) |  | (88) |  |  | 55,888 |
Commercial paper | 14,816 |  |  | 8 |  |  | (5) |  |  | 14,819 |
Corporate bonds | 4,436 |  |  | 1 |  |  | (3) |  |  | 4,434 |
Total | $ | 280,956 |  |  | $ | 127 |  |  | $ | (248) |  |  | $ | 280,835 |
Short-term deposits |  |  |  |  |  |  |
Term bank deposits | $ | 226,850 |  |  | $ | — |  |  | $ | — |  |  | $ | 226,850 |
Total | $ | 226,850 |  |  | $ | — |  |  | $ | — |  |  | $ | 226,850 |
*) Represents an amount lower than $1
| As of December 31, 2022
| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value
Cash equivalents |  |  |  |  |  |  |
Money market funds | $ | 278,022 |  |  | $ | — |  |  | $ | — |  |  | $ | 278,022 |
Total | $ | 278,022 |  |  | $ | — |  |  | $ | — |  |  | $ | 278,022 |
Marketable securities |  |  |  |  |  |  |
US Treasury securities | $ | 159,165 |  |  | $ | 2 |  |  | $ | (211) |  |  | $ | 158,956 |
US Agencies securities | 55,967 |  |  | 5 |  |  | (72) |  |  | 55,900 |
Commercial paper | 13,679 |  |  | — |  |  | — |  |  | 13,679 |
Corporate bonds | 7,804 |  |  | 4 |  |  | (5) |  |  | 7,803 |
Total | $ | 236,615 |  |  | $ | 11 |  |  | $ | (288) |  |  | $ | 236,338 |
Short-term deposits |  |  |  |  |  |  |
Term bank deposits | $ | 128,350 |  |  | $ | — |  |  | $ | — |  |  | $ | 128,350 |
Total | $ | 128,350 |  |  | $ | — |  |  | $ | — |  |  | $ | 128,350 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash, cash equivalents, and investments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration